Filing Details
- Accession Number:
- 0001209191-18-013130
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-23 17:52:51
- Reporting Period:
- 2018-02-21
- Accepted Time:
- 2018-02-23 17:52:51
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1689813 | Biohaven Pharmaceutical Holding Co Ltd. | BHVN | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1704255 | James Engelhart | C/O Biohaven Pharmaceuticals, Inc. 234 Church Street New Haven CT 06510 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Disposition | 2018-02-21 | 538 | $29.60 | 3,038 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Billionaire Hedge Funds
